Animal models of hepadnavirus-associated hepatocellular carcinoma

Clinics in Liver Disease

Volumn 5, Issue 1, 2001, Pages 43-68

  Tennant, Bud C ^b  

^a Department of Obstetrics Gynecology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; LAMIVUDINE; LOBUCAVIR; NUCLEOSIDE ANALOG; ZIDOVUDINE;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; CANCER PREVENTION; CANCER SURVIVAL; CARCINOGENICITY; CHRONICITY; GENE ACTIVATION; HEPADNAVIRUS; HEPATITIS B; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; LIFE EXPECTANCY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; MOUSE; NONHUMAN; ONCOGENE C MYB; ONCOGENE C MYC; PATHOGENESIS; REVIEW; SQUIRREL; TRANSGENIC MOUSE; VIRUS CARRIER; VIRUS REPLICATION; WOODCHUCK;

EID: 0035142201     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70153-7     Document Type: Article

References (245)

1. Hepatocellular carcinoma associated with chronic Schistosoma mansoni infection in a chimpanzee
2. Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus
3. Expression and replication of hepatitis B virus genome in transgenic mice
4. Mechanisms of action of N-nitroso compounds
5. Primary liver carcinoma and liver cirrhosis in atomic bomb survivors, Hiroshima and Nagasaki, 1961-75, with special reference to hepatitis B surface antigen
6. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice
7. Circannual changes in serum testosterone concentrations of adult and yearling woodchucks (Marmota monax)
8. 1 in woodchucks
9. Functional analysis of hepatitis B virus core promotor mutations in primary tupaia hepatocytes
10. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma - Epidemiologic considerations
11. Hepatitis B virus. The major etiology of hepatocellular carcinoma
12. Hepatoma risk among HBsAg carriers
13. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan
14. Human class I supertypes and CTL repertoires extend to chimpanzees
15. Association between synthesis and release of cGMP and nitric acid biosynthesis by hepatocytes
16. A role for inducible nitric oxide biosynthesis in the liver in inflammation and in the allogeneic immune response
17. A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis
18. The relation of infection with hepatitis B agent to primary hepatic carcinoma
19. Hepatitis B virus: Pathogenesis and prevention of primary cancer of the liver
20. Reconstructing the complex evolutionary history of hepatitis B virus
21. Hepatoma and arteriosclerosis in a woodchuck
22. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and negative liver disease
23. Serological and pathomorphological characterization of human hepatitis B virus infection in a small primate, Tupaia belangeri
24. Animal models for hepatitis B virus and liver cancer
25. The complex role of hepatitis B virus in human hepatocarcinogenesis
26. A new avian hepadnavirus infecting snow geese (Anser caerulescens) produces a significant fraction of virions containing single-stranded DNA
27. Detection and properties of hepatitis B viral DNA in liver tissues from patients with hepatocellular carcinoma
28. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks
29. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan
30. Viruses, immunity, and cancer: Lessons from hepatitis B
31. Hepatitis B virus transgenic mice: Insights into the virus and the disease
32. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice
33. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
34. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state
35. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent
36. Parasites of the laboratory woodchuck (Marmota monax)
37. Immunosuppression with cyclosporine during the incubation period of experimental woodchuck hepatitis virus infection increases the frequency of chronic infection in adult woodchucks
38. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection
39. Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity
40. New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection
41. A sequential histologic and immunohistochemical study of duck hepatitis B virus infection in Pekin ducks
42. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory stimuli
43. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis
44. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis
45. Virus-like particles in serum of patients with Australia-antigen associated hepatitis
46. Hepatitis B virus as an insertional mutagen in a human hepatocellular carcinoma
47. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
48. Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis
49. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice
50. Biology of disease-hepatocarcinogenesis: A dynamic cellular perspective
51. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome
52. Induction of 8-hydroxydeoxyguanosine in Ah-responsive mouse liver by iron and Aroclor 1254
53. Characteristics of woodchuck hepatitis X-antigen in the livers and sera from infected animals
54. Tree squirrel hepatitis B virus: Antigenic and structural characterization
55. Partial characterization of the woodchuck tumor suppressor, p53, and its interaction with woodchuck hepatitis virus X antigen in hepatocarcinogenesis
56. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors
57. Evidence for long-range oncogene activation by hepadnavirus insertion
58. The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter
59. Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter
60. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors
61. Observations upon neoplasms in wild animals in the Philadelphia Zoological Garden
62. Characterization of woodchuck hepatitis virus DNA and RNA in the hepatocellular carcinomas of woodchucks
63. A sequential study of viral DNA in serum in experimental transmission of duck hepatitis B virus
64. The molecular biology of the hepatitis B viruses
65. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
66. Hepadnavirus-induced liver cancer in woodchucks
67. The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice
68. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice
69. Molecular epidemiology of hepatitis B virus variants in nonhuman primates
70. High-level hepatitis B virus replication in transgenic mice
71. Viral clearance without destruction of infected cells during acute HBV infection
72. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections
73. Taxonomic classification of human hepatitis B virus
74. Spontaneous hepatomas in two woodchucks and a carcinoma of the testis in a badger
75. The hallmarks of cancer
76. Hepatitis B virus and primary hepatocellular carcinoma: Family studies in Korea
77. Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses
78. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA
79. Phorbol esters induce nitric oxide synthase activity in rat hepatocytes
80. Antiviral activities of oral 1-O-hexadecyl-propanediol-3-phospho-acyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection
81. Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma
82. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma
83. Identification of hepatitis B virus indigenous to chimpanzees
84. Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response
85. Virus-liver cell interactions in duck hepatitis B virus infection: A study of virus dissemination within the liver
86. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: One virus DNA genome is infectious in neonatal ducks
87. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement
88. Of woodchucks and men: The continuing story of hepatitis B and hepatocellular carcinoma
89. Cirrhosis and the aetiology of hepatocellular carcinoma
90. Woodchuck hepatitis virus infections: Very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte
91. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver
92. Stable integration of woodchuck hepatitis virus DNA in transplanted tumors and established tissue culture cells derived from a woodchuck primary hepatocellular carcinoma
93. Susceptibility of chacma baboons (Papio ursinus orientalis) to infection by hepatitis B virus
94. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide
95. HBX gene of hepatitis B virus induces liver cancer in transgenic mice
96. Differential induction of brain, lung and liver nitric oxide synthase by endotoxins in the rat
97. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: Evolutional relationship between hepadnaviruses
98. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
99. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks
100. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans
101. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication
102. Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: Presence of viral DNA in tumor issue from chronic carriers and animals serologically recovered from acute infections
103. Isolation of a hepadnavirus from the woolly monkey, a New World primate
104. Hepadnavirus infection in captive gibbons
105. Hepatitis B virus transgenic mouse model of chronic liver disease
106. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice
107. 1 adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinesis)
108. Elevated formation of nitrate and N-nitrosodimethylamine in woodchucks (Marmota monax) associated with chronic woodchuck hepatitis virus infection
109. Synthesis of nitric oxide and nitrosamine by immortalized woodchuck hepatocytes
110. Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: Possible role in hepatocarcinogenesis
111. Nitrite and nitrosamine synthesis by hepatocytes isolated from normal woodchucks (Marmota monax) and woodchucks chronically infected with woodchuck hepatitis virus
112. Hepatomas in a group of captured woodchucks
113. Cross-reactions between the hepatitis B and woodchuck hepatitis viruses
114. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): Phylogenetic relationships with human and other primate genotypes
115. Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancer
116. The experimental basis for the role of nitroso compounds in human cancer
117. Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese
118. Liver disease associated with duck hepatitis B virus infection
119. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans
120. Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus
121. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate
122. Lamivudine therapy of WHV-infected woodchucks
123. Experimental transmission of duck hepatitis B virus
124. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus
125. Hepatitis B virus infection and primary hepatocellular carcinoma: Epidemiological, clinical, and virological studies in Senegal from the perspective of prevention by active immunization
126. Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma
127. Classification of hepatitis A virus as enterovirus type 72 and hepatitis B virus as hepadnavirus type 1
128. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope
129. DNA ploidy analysis of hepatic preneoplastic and neoplastic lesions in woodchucks experimentally infected with woodchuck hepatitis virus
130. Lack of susceptibility of baboons to infection with hepatitis B virus
131. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice
132. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
133. Evidence against a requisite role for defective virus in the establishment of persistent hepadnavirus infections
134. Woodchuck hepatitis virus: Experimental infection and natural occurrence
135. Unique preS sequence in a gibbon-derived hepatitis B virus variant
136. Ground squirrel hepatitis virus (GSHV) infection and hepatocellular carcinoma in the Canadian Richardson ground squirrel (Spermophilus richardsonii)
137. Woodchuck hepatitis virus DNA in woodchuck liver tissues
138. Chimpanzee model for hepatitis non-A, non-B related hepatocellular carcinoma
139. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus
140. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice
141. Structure and expression of her, a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma
142. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks
143. Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee
144. Immune pathogenesis of hepatocellular carcinoma
145. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogenous population of viral minichromosomes
146. DNA damage and mutation in human cells exposed to nitric oxide in vitro
147. Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus
148. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen
149. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks
150. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: A comparative study of histopathology and frequency of hepatitis B markers
151. Hepatocellular carcinoma in the USA, etiologic considerations. Localization of hepatitis B antigens
152. Duck hepatitis B virus and liver disease
153. Transmission of duck hepatitis B virus from Chinese carrier ducks to Japanese ducklings: A study of viral DNA in serum and tissue
154. Molecular pathogenesis of hepatocellular carcinoma in HBV envelope transgenic mice
155. 3′-Thiacytidine (3TC) delays development of hepatocellular carcinoma (HCC) in woodchucks with experimentally induced chronic woodchuck hepatitis virus (WHV) infection. Preliminary results of a lifetime study
156. Immunopathology of glomerulonephritis associated with chronic woodchuck hepatitis virus infection in woodchucks (Marmota monax)
157. Facts and theories concerning the mechanisms of carcinogenesis
158. The relationship of hepatocellular carcinoma to infection with hepatitis B and related viruses in man and animals
159. Hepatocarcinogenicity of the woodchuck hepatitis virus
160. Woodchuck hepatitis and hepatocellular carcinoma: Correlation of histologic with virologic observations
161. An antigen detected in the blood during the incubation period of serum hepatitis
162. The risk of development of hepatocellular carcinoma in hepatitis B virus carriers in New York: A preliminary estimate using death-records matching
163. A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal
164. Modification of chronic hepatitis B virus infection in chimpanzees by administration of an interferon inducer
165. A functional N-myc2 retroposon in ground squirrels: Implications for hepadnavirus-associated carcinogenesis
166. Pharmacokinetics of (-)-2′-3′-dideoxy-3′-thiacytidine in woodchucks
167. Incidence and nature of tumors in captive mammals and birds
168. Induction of liver tumors by aflatoxin B1 in the tree shrew (Tupaia glis), a nonhuman primate
169. Hepatocellular carcinoma in WHV/N-myc 2 transgenic mice: Oncogenic mutations of β-catenin and synergistic effect of p53 null alleles
170. 1
171. The hepadnavirus group: Hepatitis B and related viruses
172. Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepadnavirus infection
173. Molecular aspects of persistent woodchuck hepatitis virus and hepatitis B virus infection and hepatocellular carcinoma
174. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver
175. Chronic hepatitis and hepatocellular carcinoma associated with persistent woodchuck hepatitis virus infection
176. Hepatocellular carcinoma
177. Animal hepatitis B viruses
178. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army
179. Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host
180. Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus
181. Biochemical and genetic evidence for the hepatitis B virus replication strategy
182. In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels
183. Hepatitis B virus biology
184. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein
185. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice
186. Hepatitis B virus DNA molecules in the liver of hepatitis B surface antigen carriers: Mechanistic considerations in the pathogenesis of hepatocellular carcinoma
187. Mapping of the cellular immune responses to woodchuck hepatitis core antigen epitopes in chronically infected woodchucks
188. Chronic liver disease and primary liver-cell cancer with hepatitis associated (Australia) antigen in serum
189. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene
190. Hepatomas of captive woodchucks
191. Marmota monax: A model for studies of cardiovascular, cerebrovascular and neoplastic disease
192. Woodchuck hepatitis virus and hepatocellular carcinoma
193. Chronic hepatitis and hepatocellular carcinoma associated with woodchuck hepatitis virus
194. Isolation and characterization of a hepatitis B virus endemic in herons
195. Cloned duck hepatitis B virus DNA is infectious in Pekin ducks
196. The replication cycle of hepatitis B viruses
197. Three recently described animal virus models for human hepatitis B
198. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate
199. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification
200. Morphogenic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus
201. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks
202. Hepatitis B virus and woodchuck hepatitis virus are members of a novel class of DNA viruses
203. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association
204. Hepatitis B virus infection and primary hepatocellular carcinoma
205. Histochemical and immunohistochemical similarities between hepatic tumors in two chimpanzees and man
206. Full-genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: Implications for an origin of HBV
207. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults
208. Animal models of hepatitis B virus infection
209. Hepatocarcinogenesis in experimental woodchuck hepatitis virus infection
210. Antiviral activity of BMS-180194 in the woodchuck model of hepatitis B virus infection
211. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection
212. Animal models in the preclinical assessment of therapy for viral hepatitis
213. Influence of age on the response to experimental woodchuck hepatitis virus infection
214. 1 on experimental woodchuck hepatitis virus infection and hepatocellular carcinoma
215. Hepatocellular carcinoma in Richardson's ground squirrels (Spermophilus richardsonii): Evidence for association with hepatitis B-like virus infection
216. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice
217. A new hepadnavirus endemic in arctic ground squirrels in Alaska
218. The hepatitis B virus
219. Hepatic preneoplasia in hepatitis B virus transgenic mice
220. Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus
221. Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus
222. Transmission of ground squirrel hepatitis virus to homologous and heterologous hosts
223. Antiviral activities and pharmacokinetics of penciclovir and famciclovir in Pekin ducks chronically infected with duck hepatitis B virus
224. Experimental infection of the woodchuck (Marmota monax monax) with woodchuck hepatitis virus
225. Woodchuck hepatitis virus in natural woodchuck population
226. Functional inactivation but not structural mutation of p53 causes liver cancer
227. DHBV manipulation and prediction of the outcome of infection
228. Natural history of liver disease in chronic hepatitis B surface antigen carriers
229. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo
230. A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus)
231. Seroprevalence of specific viral infections in confiscated orangutans (Pongo pygmaeus)
232. Hepadnavirus integration: Mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors
233. In vivo effects of mutations in woodchuck hepatitis virus enhancer II
234. Closed circular DNA and asymmetrical heterogenous forms in livers from animals infected with ground squirrel hepatitis virus
235. Cloned HBV DNA causes hepatitis in chimpanzees
236. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors
237. Natural and experimental infection of woodchucks with woodchuck hepatitis virus as measured by new specific assays for woodchuck surface antigen and antibody
238. Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene
239. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus
240. Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1
241. Coordinate expression of N-myc 2 and insulin-like growth factor II in pre-cancerous altered hepatic foci in woodchuck hepatitis virus carriers
242. Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells
243. The woodchuck, Marmota monax, as a laboratory animal
244. Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine
245. Hepatitis B outbreak among chimpanzees at the London Zoo